Google's WebMCP protocol lets AI agents execute structured actions on websites via browser APIs. Is this the next frontier of ...

IoT penetration testing is a security assessment of the complete IoT ecosystem, from backend systems and cloud services to mobile devices and hardware. It involves a multi-stage simulated attack on ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting against it for years, supporting only companies that do not use wildlife for ...

Tom Fenton used AI-assisted vibe coding to create and deploy a free, cloud-hosted static web page. GitHub Pages provided a no-cost way to host static HTML content without servers, databases, or paid ...

The digital economy is shifting faster than most teams can adapt. The Epic vs. Apple ruling, which loosened the App Store’s control over payment flows, simply accelerated a transition that was already ...

Testing products on animals became an industry standard in the cosmetic, chemical, and pharmaceutical industries nearly a century ago. Since that time, it has become clear that these tests cause ...

In a move that could redefine the web, Google is testing AI-powered, UI-based answers for its AI mode. Up until now, Google AI mode, which is an optional feature, has allowed you to interact with a ...

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

OpenAI is entering the browser world with the launch of ChatGPT Atlas, an AI-enabled browser. Atlas, now available globally, can be accessed through Apple’s macOS, with support for Windows, iOS and ...

Abstract: As modern web services increasingly rely on REST APIs, their thorough testing has become crucial. Furthermore, the advent of REST API documentation languages, such as the OpenAPI ...

Julie E. Gough is professor of biomaterials and tissue engineering in the Department of Materials, School of Natural Sciences and NIHR Manchester Biomedical Research Centre, University of Manchester, ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such ...